Daniel Branstetter

Daniel Branstetter

UNVERIFIED PROFILE

Are you Daniel Branstetter?   Register this Author

Register author
Daniel Branstetter

Daniel Branstetter

Publications by authors named "Daniel Branstetter"

Are you Daniel Branstetter?   Register this Author

21Publications

548Reads

6Profile Views

Receptor activator of NF-κB (RANK)-mediated induction of metastatic spread and association with poor prognosis in renal cell carcinoma.

Urol Oncol 2018 11 28;36(11):502.e15-502.e24. Epub 2018 Aug 28.

Department of Urology, University Medicine at the Ernst-Moritz-Arndt University Greifswald, Greifswald, Germany; Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine at the University of California, Los Angeles, CA; Institute of Medical Biochemistry and Molecular Medicine, University Medicine at the Ernst-Moritz-Arndt University Greifswald, Greifswald, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2018.07.013DOI Listing
November 2018

Distribution of RANK and RANK Ligand in Normal Human Tissues as Determined by an Optimized Immunohistochemical Method.

Appl Immunohistochem Mol Morphol 2017 May/Jun;25(5):299-307

*Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles ‡Dako, an Agilent technologies company, Carpinteria ∥Department of Comparative Biology and Safety Sciences ¶Formerly Department of Pathology, Amgen Inc., Thousand Oaks, CA †Formerly Department of Pathology §Department of Oncology Research, Amgen Inc., Seattle WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000503DOI Listing
November 2017

Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression.

Breast Cancer Res Treat 2017 Jul 17;164(1):57-67. Epub 2017 Apr 17.

Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-017-4233-5
Publisher Site
http://dx.doi.org/10.1007/s10549-017-4233-5DOI Listing
July 2017

RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.

Nat Med 2016 08 20;22(8):933-9. Epub 2016 Jun 20.

ACRF Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research (WEHI), Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.4118DOI Listing
August 2016

RANK and RANK ligand expression in primary human osteosarcoma.

J Bone Oncol 2015 Sep 29;4(3):59-68. Epub 2015 Jul 29.

Therapeutic Innovation Unit, Amgen Inc., Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbo.2015.06.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986823PMC
September 2015

Intravital imaging reveals distinct responses of depleting dynamic tumor-associated macrophage and dendritic cell subpopulations.

Proc Natl Acad Sci U S A 2014 Nov 10;111(47):E5086-95. Epub 2014 Nov 10.

Department of Anatomy, University of California, San Francisco, CA 94143; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1419899111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250128PMC
November 2014

RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase.

Breast Cancer Res Treat 2014 Aug 10;146(3):515-23. Epub 2014 Jul 10.

Department of Surgery, Northwestern University Feinberg School of Medicine, 303 E. Superior Street Lurie 4-111, Chicago, IL, 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-3049-9DOI Listing
August 2014

RANK expression as a prognostic and predictive marker in breast cancer.

Breast Cancer Res Treat 2014 Jun 16;145(2):307-15. Epub 2014 Apr 16.

Institute of Pathology, Campus Mitte, Charité University Hospital Berlin, Charitéplatz 1, 10117, Berlin, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2955-1DOI Listing
June 2014

RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model.

Breast Cancer Res Treat 2012 Oct 29;135(3):771-80. Epub 2012 Aug 29.

Department of Oncology Research, Amgen Inc, 1 Amgen Center Drive, Thousand Oaks, CA 91320, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2222-2DOI Listing
October 2012

Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells.

Apoptosis 2007 Aug;12(8):1465-78

Department of Oncology, Amgen Inc., 1201 Amgen Ct. West, Seattle, WA 98119, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10495-007-0076-6DOI Listing
August 2007

Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha.

J Biol Chem 2004 Dec 14;279(52):54841-8. Epub 2004 Oct 14.

Department of Cancer Biology, Amgen Incorporated, Seattle, Washington 98119, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M406392200DOI Listing
December 2004